Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock Class A
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 28, 2023   106,738,000      
Beginning balance at Dec. 28, 2023 $ 1,930,990 $ 107 $ 513,060 $ 1,422 $ 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 7,232   7,232    
Exercise of stock options (in shares)   171,000      
Exercise of stock options 3,854   3,854    
Issuance of common stock upon vesting of restricted stock units (in shares)   184,000      
Shares issued under employee stock purchase plan (in shares)   28,000      
Shares issued under employee stock purchase plan 2,720   2,720    
Common stock redeemed for tax liability (in shares)   (110,000)      
Common stock redeemed for tax liability (13,057)   (13,057)    
Other comprehensive (loss) gain, net of tax (970)     (970)  
Net income 50,032       50,032
Ending balance (in shares) at Mar. 28, 2024   107,011,000      
Ending balance at Mar. 28, 2024 1,980,801 $ 107 513,809 452 1,466,433
Beginning balance (in shares) at Dec. 28, 2023   106,738,000      
Beginning balance at Dec. 28, 2023 1,930,990 $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive (loss) gain, net of tax (1,316)        
Net income 106,698        
Ending balance (in shares) at Jun. 27, 2024   107,133,000      
Ending balance at Jun. 27, 2024 2,046,594 $ 107 523,282 106 1,523,099
Beginning balance (in shares) at Mar. 28, 2024   107,011,000      
Beginning balance at Mar. 28, 2024 1,980,801 $ 107 513,809 452 1,466,433
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 8,355   8,355    
Exercise of stock options (in shares)   112,000      
Exercise of stock options 1,588   1,588    
Issuance of common stock upon vesting of restricted stock units (in shares)   13,000      
Common stock redeemed for tax liability (in shares)   (3,000)      
Common stock redeemed for tax liability (470)   (470)    
Other comprehensive (loss) gain, net of tax (346)     (346)  
Net income 56,666       56,666
Ending balance (in shares) at Jun. 27, 2024   107,133,000      
Ending balance at Jun. 27, 2024 $ 2,046,594 $ 107 523,282 106 1,523,099
Beginning balance (in shares) at Dec. 26, 2024 107,356,999 107,357,000      
Beginning balance at Dec. 26, 2024 $ 2,170,158 $ 107 547,818 (40) 1,622,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 6,580   6,580    
Exercise of stock options (in shares)   50,000      
Exercise of stock options 1,288   1,288    
Issuance of common stock upon vesting of restricted stock units (in shares)   247,000      
Issuance of common stock upon vesting of restricted stock units 0 $ 1 (1)    
Shares issued under employee stock purchase plan (in shares)   36,000      
Shares issued under employee stock purchase plan 3,081   3,081    
Common stock redeemed for tax liability (in shares)   (84,000)      
Common stock redeemed for tax liability (8,212)   (8,212)    
Other comprehensive (loss) gain, net of tax (10)     (10)  
Net income 48,878       48,878
Ending balance (in shares) at Mar. 27, 2025   107,606,000      
Ending balance at Mar. 27, 2025 $ 2,221,763 $ 108 550,554 (50) 1,671,151
Beginning balance (in shares) at Dec. 26, 2024 107,356,999 107,357,000      
Beginning balance at Dec. 26, 2024 $ 2,170,158 $ 107 547,818 (40) 1,622,273
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 73,485        
Other comprehensive (loss) gain, net of tax $ 11        
Net income $ 112,056        
Ending balance (in shares) at Jun. 26, 2025 107,637,510 107,638,000      
Ending balance at Jun. 26, 2025 $ 2,294,342 $ 108 559,934 (29) 1,734,329
Beginning balance (in shares) at Mar. 27, 2025   107,606,000      
Beginning balance at Mar. 27, 2025 2,221,763 $ 108 550,554 (50) 1,671,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 8,922   8,922    
Exercise of stock options (in shares)   23,000      
Exercise of stock options 754   754    
Issuance of common stock upon vesting of restricted stock units (in shares)   12,000      
Common stock redeemed for tax liability (in shares)   (3,000)      
Common stock redeemed for tax liability (296)   (296)    
Other comprehensive (loss) gain, net of tax 21     21  
Net income $ 63,178       63,178
Ending balance (in shares) at Jun. 26, 2025 107,637,510 107,638,000      
Ending balance at Jun. 26, 2025 $ 2,294,342 $ 108 $ 559,934 $ (29) $ 1,734,329